Immunosuppressant Therapy in Small Animal Medicine: What, When, and Why

Today's Vet Pract. Jul-Aug 2023;13(4):83-93. 49 Refs

Stuart A Walton¹, Alexis Hoelmer

¹ University of Florida College of Veterinary Medicine, Gainesville, Florida 32608, USA.

Author Abstract

Glucocorticoids are considered the mainstay of immunosuppressive therapy; however, clinicians should be aware of second-line or alternative agents.

Article Tools:

Email to me

Archives Highlights:

Toxicity of House Plants to Pet Animals.
This review article describes in detail the most common and popular indoor poisonous plants grown in Europe, the mechanisms of action of their active substances and clinical signs of the respective poisonings. This manuscript is supplemented with rich photographic documentation of these plants not found in similar articles, and also includes a description of the treatment of individual types of poisoning.

A review of adverse events in animals and children after secondary exposure to transdermal hormone-containing medicinal products.
The clinical signs reported in animals included persistent signs of oestrus, poor growth rate, and birth defects. In humans, reported clinical signs included precocious puberty, unresolved virilisation, accelerated growth rate, and female infertility.

Head Trauma Management in Small Animals
This article reviews the pathophysiology of head trauma, patient assessment, diagnostic testing, treatment recommendations, monitoring, and prognosis.

Neoplasms in Domestic Ruminants and Swine: A Systematic Literature Review.
In all species, the most frequent neoplasms were squamous cell carcinomas in ruminants, while melanoma was the most frequent in swine.

Risk factors for unilateral cranial cruciate ligament rupture diagnosis and for clinical management in dogs under primary veterinary care in the UK.
After accounting for confounding factors, dogs aged 6 to less than 9 years, male neutered and female neutered dogs, insured dogs, and Rottweiler, Bichon Frise, and West Highland White terrier breeds, in particular, had increased odds of unilateral CCL rupture diagnosis. Insured dogs and dogs = 20 kg had increased odds of surgical management, while dogs = 9 years and dogs with one non-orthopaedic comorbidity at diagnosis with CCL rupture had reduced odds. These findings inform identification of at-risk dogs.